Clinical Trials Directory

Trials / Completed

CompletedNCT02848885

The Effects of tDCS on Illness Awareness in Schizophrenia

The Clinical and Functional Imaging Effects of Transcranial Direct Current Stimulation (tDCS) on Illness Awareness in Schizophrenia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a novel study that seeks to explore the clinical and functional imaging effects of transcranial direct current stimulation (tDCS) on illness awareness or anosognosia in schizophrenia, arguably the most treatment-resistant manifestation of the disorder.

Detailed description

Transcranial DCS is a novel, non-invasive and non-convulsive technique for altering brain function. To our knowledge, no research has investigated the functional and behavioural effects of tDCS on anosognosia in schizophrenia. As such, we aim to improve impaired illness awareness in schizophrenia with tDCS by inhibiting left hemisphere regions (i.e. temporoparietooccipital cortex) shown by our group to be activated during illness denial. Positive results will demonstrate that impaired illness awareness in schizophrenia involves a similar brain network to impaired illness awareness in patients with brain lesions and can be similarly modulated with non-invasive techniques, such as tDCS. If proven effective, this easy to administer, safe, non-invasive intervention would have the potential to alter individuals' attitude towards their illness and medication, leading ultimately to an improvement in individuals' capacity for illness recognition and treatment engagement, which would undoubtedly have a significant impact on the management of this devastating mental disorder.

Conditions

Interventions

TypeNameDescription
OTHERActive TDCSParticipants will receive active tDCS stimulation.
OTHERSham TDCSParticipants will receive sham tDCS stimulation

Timeline

Start date
2016-08-01
Primary completion
2025-05-13
Completion
2025-05-13
First posted
2016-07-29
Last updated
2025-06-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02848885. Inclusion in this directory is not an endorsement.